Featured News
AIM Blog
States Take on the Era of Treatment
This article originally appeared in the 2025 Impact Report. Become a member today to get access to additional exclusive content, meetings and insights into the Alzheimer's and dementia public policy c...
All News
AIM Blog
State Legislatures Take Action: Supporting Caregivers Through Respite Care
Col. Thomas G. Bowden of Tennessee served for 26 years in the United States Army and commanded more than 900...
AIM Blog
Recognizing AIM’s August Advocate of the Month: Darlene Bradley
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Senate Passes Bipartisan Bills to Renew Nation’s Commitment to Addressing Alzheimer’s
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., July 30, 2024 — Today the Senate unanimously passed...
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to...
AIM Blog
Recognizing AIM’s July Advocate of the Month: Molina Gonzales
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™...